While Lundbeck’s pentobarbital continues to kill at an increasing and disgusting pace in the United States, the Danish death laboratory is publicizing that it will soon apply to the European Medicines Agency (an agency of the European Union) for a marketing authorization for its new drug Nalmefene. So let’s see if we can’t help Mr. Ulf Wiinberg, Lundbeck CEO, get his priorities in the right order for a change.
So far, more than six months after the first pentobarbital execution in the United States and 15 murdered Lundbeck patients later, Mr. Ulf Wiinberg still does not seem to care for human lives at all, however profit margins and corporate image are obviously his forte.
For now and to take care of the first issue, “Lundbeck, the chronic ethics and human rights violator”, click here to tell the European Medicines Agency why Lundbeck must not be granted any new marketing authorization until it truly stops violating medical ethics and human rights.
And tonight June 21 in Texas, Milton Mathis awaits to be killed with Lundbeck’s pentobarbital, his family, friends and legal team are holding their breath, anxious and terrified by the probable outcome of Lundbeck’s criminal negligence. No matter what Lundbeck’s good intentions may be, the reality is that of a death laboratory that will never make up for the damage done.